GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Capital Expenditure

Medartis Holding AG (XSWX:MED) Capital Expenditure : CHF-18.81 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Medartis Holding AG's cash flow for capital expenditures for the six months ended in Dec. 2023 was CHF-9.8 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-18.81 Mil.


Medartis Holding AG Capital Expenditure Historical Data

The historical data trend for Medartis Holding AG's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG Capital Expenditure Chart

Medartis Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.42 -13.07 -10.39 -18.79 -18.81

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.79 -8.20 -10.59 -9.01 -9.80

Medartis Holding AG Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-18.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG (XSWX:MED) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for Cranium, Midface, and mandible. Geographically, it derives majority of the revenue from EMEA and also has a presence in APAC; LATAM and North America.

Medartis Holding AG (XSWX:MED) Headlines

From GuruFocus

OPTAVIA ACTIVE� Now Available

By PRNewswire 09-13-2023

Medifast Announces Quarterly Dividend

By PRNewswire PRNewswire 12-08-2022

Medifast Announces Quarterly Dividend

By PRNewswire PRNewswire 06-15-2023

Medifast Announces First Quarter 2023 Financial Results

By PRNewswire PRNewswire 05-01-2023

Medifast, Inc. Announces Quarterly Dividend

By PRNewswire PRNewswire 07-06-2022